BE862290A - Immunoglobuline avec fixation attenuee du complement, son procede de preparation, et medicament la contenant - Google Patents

Immunoglobuline avec fixation attenuee du complement, son procede de preparation, et medicament la contenant

Info

Publication number
BE862290A
BE862290A BE183818A BE183818A BE862290A BE 862290 A BE862290 A BE 862290A BE 183818 A BE183818 A BE 183818A BE 183818 A BE183818 A BE 183818A BE 862290 A BE862290 A BE 862290A
Authority
BE
Belgium
Prior art keywords
immunoglobulin
complement
preparation process
product containing
medicinal product
Prior art date
Application number
BE183818A
Other languages
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of BE862290A publication Critical patent/BE862290A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BE183818A 1976-12-23 1977-12-23 Immunoglobuline avec fixation attenuee du complement, son procede de preparation, et medicament la contenant BE862290A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2658334A DE2658334B2 (de) 1976-12-23 1976-12-23 Verfahren zum Herstellen von Immunglobulinpraparationen mit verminderter Komplementbindung und ein diese enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
BE862290A true BE862290A (fr) 1978-06-23

Family

ID=5996330

Family Applications (1)

Application Number Title Priority Date Filing Date
BE183818A BE862290A (fr) 1976-12-23 1977-12-23 Immunoglobuline avec fixation attenuee du complement, son procede de preparation, et medicament la contenant

Country Status (18)

Country Link
US (1) US4160763A (fr)
JP (1) JPS5379023A (fr)
AT (1) AT359638B (fr)
BE (1) BE862290A (fr)
BR (1) BR7708559A (fr)
CA (1) CA1105383A (fr)
CH (1) CH639394A5 (fr)
DE (1) DE2658334B2 (fr)
DK (1) DK151610C (fr)
ES (1) ES465180A1 (fr)
FR (1) FR2375247A1 (fr)
GB (1) GB1598080A (fr)
IL (1) IL53670A (fr)
IN (1) IN146967B (fr)
MX (1) MX4329E (fr)
NL (1) NL190473C (fr)
PT (1) PT67436B (fr)
SE (1) SE7714647L (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
DE2853453A1 (de) * 1978-12-11 1980-06-19 Behringwerke Ag Mittel zur therapie von immunkomplexerkrankungen
CA1153695A (fr) * 1979-08-30 1983-09-13 Syoji Ono Compose d'immunoglobuline s-sulfone a forte teneur en monomeres et procede de production
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4442032A (en) * 1980-12-04 1984-04-10 Lilly Industries Limited Isothiocyanato-azobenzene-sulfonic, arsonic and substituted-glutamic acid haptens
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
AU2014346343B2 (en) 2013-11-08 2018-05-10 Csl Ltd. New method to concentrate von Willebrand factor or complexes thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2404265C3 (de) * 1974-01-30 1980-05-29 Behringwerke Ag, 3550 Marburg Verfahren zum Abreichen von Immunglobulinen
DE2508132C3 (de) * 1974-03-08 1980-10-16 Teijin Ltd., Osaka (Japan) Verfahren zur Herstellung von Humanimmunglobulin-Derivaten und parenteral applizierbare Lösung hiervon
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
JPS5234918A (en) * 1975-09-06 1977-03-17 Biotest Serum Institut Gmbh Production of gmmaglobulin suitable for dosing into vein
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin

Also Published As

Publication number Publication date
ES465180A1 (es) 1979-01-01
DK151610B (da) 1987-12-21
PT67436A (de) 1978-01-01
FR2375247A1 (fr) 1978-07-21
AT359638B (de) 1980-11-25
DE2658334B2 (de) 1980-06-04
GB1598080A (en) 1981-09-16
DE2658334A1 (de) 1978-06-29
IN146967B (fr) 1979-10-20
FR2375247B1 (fr) 1980-11-28
MX4329E (es) 1982-03-25
NL7713980A (nl) 1978-06-27
US4160763A (en) 1979-07-10
CA1105383A (fr) 1981-07-21
IL53670A (en) 1980-10-26
NL190473B (nl) 1993-10-18
JPS5379023A (en) 1978-07-13
PT67436B (de) 1979-09-20
DE2658334C3 (fr) 1987-05-07
NL190473C (nl) 1994-03-16
ATA922777A (de) 1980-04-15
DK574577A (da) 1978-06-24
SE7714647L (sv) 1978-06-24
DK151610C (da) 1988-06-20
CH639394A5 (de) 1983-11-15
BR7708559A (pt) 1978-08-15

Similar Documents

Publication Publication Date Title
BE860726A (fr) Nouveaux aryl-acylamides n-(2-aminocy-cloaliphatiques), leur procede de preparation et medicament les contenant
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
BE860727A (fr) Nouveaux benzamides trans-n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant
FR2273522A2 (fr) Nouveau derive d'alcanolamine, son procede de preparation et medicament le contenant
FR2307543A1 (fr) Nouveaux amides peptidiques, leur procede de preparation et medicament les contenant
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
BE862290A (fr) Immunoglobuline avec fixation attenuee du complement, son procede de preparation, et medicament la contenant
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
BE858269A (fr) Nouvelles aminoalkylidenamino-1,4-dihydropyridines, leur procede de preparation et medicament les contenant
FR2287435A1 (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4-pyranones-2
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
BE826982A (fr) Medicament en vue d'eviter les symptomes uremiques et son procede de preparation
BE838213A (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
BE862278A (fr) Nouveaux composes heterocycliques, leur procede de preparation et medicament les contenant
FR2342069A1 (fr) Nouvelles benzodiazepinones, leur procede de preparation et medicament les contenant
BE831421A (fr) Nouvelles phenylisothiourees substituees, leur procede de preparation et medicament les contenant
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
FR2346354A1 (fr) Nouvelles as-triazinobenzodiazepine-1-ones, leur procede de preparation et medicament les contenant
BE825245A (fr) Nouvelles 2-amino-6-dialkylaminodihydropyridines leur procede de preparation et medicament les contenant
FR2291753A1 (fr) Nouveau derive de 5,7-dihydroxy-tetrahydroisoquinoleine, son procede de preparation et medicament le contenant
FR2340316A1 (fr) Nouveau sel de piperazinyluracile, son procede de preparation et medicaments le contenant
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
FR2346352A1 (fr) Nouvelles triazinobenzodiazepines, leur procede de preparation et medicament les contenant
FR2348924A1 (fr) Nouvelles carbonylpiperazinylquinazolines azoliques,leur procede de preparation et medicament les contenant
BE863851A (fr) 2,4-dichlorophenyl-imidazolyl-ethanones ou -ethanols, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BEHRINGWERKE A.G.

Effective date: 19971223